Management of Hepatitis C in HIV Infected Injection Drug Users (IDUs)

CompletedOBSERVATIONAL
Enrollment

828

Participants

Timeline

Start Date

March 31, 2021

Primary Completion Date

March 31, 2021

Study Completion Date

March 31, 2021

Conditions
HIV InfectionHepatitis C
Trial Locations (1)

21287

Johns Hopkins Hospital, Baltimore

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

Johns Hopkins University

OTHER

NCT01448915 - Management of Hepatitis C in HIV Infected Injection Drug Users (IDUs) | Biotech Hunter | Biotech Hunter